At a glance
- Originator Takeda
- Class Small molecules
- Mechanism of Action Immunosuppressants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
Most Recent Events
- 12 Jun 2000 No-Development-Reported for Transplant rejection in Japan (Unknown route)